Vaxart, Inc. (VXRT) Form 10-Q Quarterly Reports
Vaxart, Inc. (VXRT) is a publicly traded company on the OTC, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: VXRT
CIK: 72444
Exchange: OTC
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
WithumSmith+Brown, PC
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerRobert Thomas
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-14 | 2026-09-03 | FORM 8-K | 0001437749-26-030318 | View SEC Doc Filr Page |
| 8-K | 2026-08-25 | 2026-08-21 | FORM 8-K | 0001437749-26-028916 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | FORM 10-Q | 0001437749-26-026289 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | FORM 8-K | 0001437749-26-026280 | View SEC Doc Filr Page |
| 8-K | 2026-07-28 | 2026-07-27 | FORM 8-K | 0001437749-26-024560 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-16 | FORM 4 | 0001437749-26-023863 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-16 | FORM 4 | 0001437749-26-023810 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-16 | FORM 4 | 0001437749-26-023809 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-16 | FORM 4 | 0001437749-26-023808 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-16 | FORM 4 | 0001437749-26-023807 | View SEC Doc Filr Page |
| 8-K | 2026-07-17 | 2026-07-16 | FORM 8-K | 0001437749-26-023762 | View SEC Doc Filr Page |
| 8-K | 2026-07-07 | 2026-07-06 | FORM 8-K | 0001437749-26-022876 | View SEC Doc Filr Page |
| DEFA14A | 2026-07-06 | — | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-26-075169 | View SEC Doc Filr Page |
| DEFA14A | 2026-07-02 | — | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-26-075088 | View SEC Doc Filr Page |
| DFAN14A | 2026-07-02 | — | DFAN14A Filing | 0000921895-26-001714 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-07-01 | CURRENT REPORT | 0001213900-26-074576 | View SEC Doc Filr Page |
| DEFA14A | 2026-07-01 | — | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-26-074234 | View SEC Doc Filr Page |
| DEFA14A | 2026-06-26 | — | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-26-072735 | View SEC Doc Filr Page |
| DEFA14A | 2026-06-26 | — | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-26-072727 | View SEC Doc Filr Page |
| 8-K | 2026-06-26 | 2026-06-22 | FORM 8-K | 0001437749-26-021833 | View SEC Doc Filr Page |
| DEFA14A | 2026-06-26 | — | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-26-072363 | View SEC Doc Filr Page |
| DEFA14A | 2026-06-26 | — | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-26-072359 | View SEC Doc Filr Page |
| DFAN14A | 2026-06-22 | — | DFAN14A Filing | 0000921895-26-001641 | View SEC Doc Filr Page |
| DEFA14A | 2026-06-16 | — | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-26-069336 | View SEC Doc Filr Page |
| DEFA14A | 2026-06-16 | — | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-26-069053 | View SEC Doc Filr Page |